Description
Dear Friends and Colleagues,
We have great pleasure in inviting you to participate in the 13th 13th World Congress on Cancers of the Skin 2010 (WCCS) that will be held in Madrid, the capital of Spain, from April 7-10, 2010. Six years ago, the delegates of the Skin Cancer Foundation had to choose the venue for the 9th World Congress, which was then held in Seville (Spain). The preparations for the Congress were undertaken by the Spanish Association of Skin Cancer (ASECCUT) together with the Spanish Academy of Dermatology and Venereology (AEDV), and was a great success. Now that the World Congress will be held in Spain for a second time, the ASECCUT and the AEDV made a proposal to the Skin Cancer Foundation for the 13th WCCS to be held in Madrid, which has become a consolidated congress venue. Experience has proven that the congresses held in Madrid have always fulfilled their participants’ expectations. The recent Centennial Congress of the Spanish Academy of Dermatology is an example. In a year of changes and difficulties, such as this one, the fact that this Congress has once again returned to Spain, also has a general and very relevant symbolic meaning. The 13th World Congress on Cancers of the Skin 2010 in Madrid has been made possible thanks to the magnificent work done by our colleagues in Madrid to further the growth and improvement of our Association.
The Local Organising Committee is very proud to host dermatologists, oncologists, epidemiologists, physicians and all the world’s best professionals who work in the field of skin cancer. The venue of the 13th WCCS will be the Hotel Meliá Castilla, which is already well-known to many of you from the various congresses held there by the International Society of Dermatologic Surgery and other international Symposia. Its location and many conference rooms make it ideally suited for this type of Congress. In general lines, the scientific programme has been designed to reflect the ongoing endeavour of the ASECCUT and AEDV to make available to their members the latest developments in dermatological science and it will surely be welcomed by those attending the congress. The programme will feature plenary sessions, symposia and satellite symposia that will provide ample opportunities to get up to date on epidemiology, diagnostics and therapeutic developments relating to Skin Cancers. The Evening Session on Public Education around the World will be of special interest, and also has press participation.
